Edesa Biotech Inc (EDSA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $26.21M
Last updated: Nov 17, 2026 at 11:04 AM ET
Edesa Biotech Inc (EDSA) Earnings: Report Dates and Results
Edesa Biotech (EDSA) is expected to report earnings on Dec 10, 2026. In the quarter ended Jun 30, 2026, Edesa Biotech reported EPS of -$0.60, below the -$0.44 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
EDSA has an expected report date of Dec 10, 2026.
Earnings History
Of the 37 quarters below that had an estimate, EDSA beat 19, missed 16 and matched 2. The widest gap in the table came in the quarter ended Mar 31, 2018, when EPS landed 900.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.60 | -$0.44 | -$0.49 - -$0.38 | -36.36% | Miss | N/A | 2 | 0 up, 1 down | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$0.49 | -$0.26 | -$0.28 - -$0.24 | -88.46% | Miss | N/A | 2 | 1 up, 0 down | May 14, 2026 | $50918 |
| Dec 31, 2025 | -$0.28 | -$0.45 | -$0.80 - -$0.25 | +37.78% | Beat | N/A | 3 | 0 up, 0 down | Feb 13, 2026 | N/A |
| Sep 30, 2025 | -$0.32 | -$0.56 | N/A | +42.86% | Beat | N/A | 3 | 0 up, 0 down | Dec 12, 2025 | N/A |
| Jun 30, 2025 | -$0.25 | -$0.26 | N/A | +3.85% | Beat | N/A | N/A | 0 up, 0 down | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$0.30 | -$0.29 | N/A | -3.45% | Miss | N/A | N/A | 0 up, 0 down | May 14, 2025 | N/A |
| Dec 31, 2024 | -$0.48 | -$0.31 | N/A | -54.84% | Miss | N/A | N/A | 0 up, 0 down | Feb 14, 2025 | N/A |
| Sep 30, 2024 | -$0.29 | -$0.54 | N/A | +46.30% | Beat | N/A | N/A | 0 up, 0 down | Dec 13, 2024 | N/A |
| Jun 30, 2024 | -$0.52 | -$0.58 | -$0.71 - -$0.45 | +10.34% | Beat | N/A | 2 | 0 up, 0 down | Aug 9, 2024 | N/A |
| Mar 31, 2024 | -$0.58 | -$0.69 | -$0.83 - -$0.61 | +15.94% | Beat | N/A | 3 | 0 up, 0 down | May 10, 2024 | N/A |
| Dec 31, 2023 | -$0.54 | -$1.21 | -$1.62 - -$0.80 | +55.37% | Beat | N/A | 2 | 0 up, 0 down | Feb 9, 2024 | N/A |
| Sep 30, 2023 | -$0.60 | -$0.71 | -$0.73 - -$0.68 | +15.49% | Beat | N/A | 3 | 0 up, 0 down | Dec 15, 2023 | N/A |
| Jun 30, 2023 | -$0.70 | -$1.21 | -$1.75 - -$0.84 | +42.15% | Beat | N/A | 3 | 0 up, 0 down | Aug 9, 2023 | N/A |
| Mar 31, 2023 | -$0.84 | -$1.21 | -$1.68 - -$0.91 | +30.58% | Beat | N/A | 3 | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$0.91 | -$1.33 | -$1.47 - -$1.19 | +31.58% | Beat | N/A | 2 | 0 up, 0 down | Feb 10, 2023 | $1.12M |
| Sep 30, 2022 | -$0.02 | -$0.39 | -$0.43 - -$0.36 | +94.87% | Beat | N/A | 2 | 0 up, 0 down | Dec 16, 2022 | N/A |
| Jun 30, 2022 | -$2.59 | -$3.01 | N/A | +13.95% | Beat | N/A | N/A | 0 up, 0 down | Aug 12, 2022 | N/A |
| Mar 31, 2022 | -$2.31 | -$2.57 | -$2.87 - -$2.10 | +10.12% | Beat | N/A | 3 | 0 up, 0 down | May 13, 2022 | N/A |
| Dec 31, 2021 | -$0.33 | -$0.40 | -$0.40 - -$0.40 | +17.50% | Beat | N/A | 1 | 0 up, 0 down | Feb 14, 2022 | N/A |
| Sep 30, 2021 | -$2.86 | -$2.94 | -$2.94 - -$1.89 | +2.72% | Beat | N/A | 3 | 0 up, 0 down | Dec 28, 2021 | N/A |
| Jun 30, 2021 | -$3.20 | -$0.98 | N/A | -226.53% | Miss | N/A | 2 | N/A | Aug 13, 2021 | N/A |
| Mar 31, 2021 | -$5.67 | -$2.73 | -$2.73 - -$1.40 | -107.69% | Miss | N/A | 2 | N/A | May 14, 2021 | N/A |
| Dec 31, 2020 | -$1.82 | -$1.54 | -$1.54 - -$1.12 | -18.18% | Miss | N/A | 2 | N/A | Feb 16, 2021 | $500 |
| Sep 30, 2020 | -$0.22 | -$0.20 | -$0.23 - -$0.18 | -10.00% | Miss | N/A | 2 | N/A | Dec 7, 2020 | $500 |
| Jun 30, 2020 | -$1.40 | -$1.61 | -$1.61 - -$1.26 | +13.04% | Beat | N/A | 2 | N/A | Aug 12, 2020 | $109985 |
| Mar 31, 2020 | -$1.19 | -$1.82 | -$1.82 - -$0.84 | +34.62% | Beat | N/A | 2 | N/A | May 15, 2020 | $110516 |
| Dec 31, 2019 | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 13, 2020 | $107800 |
| Sep 30, 2019 | -$0.55 | -$1.74 | N/A | +68.39% | Beat | N/A | N/A | N/A | Dec 12, 2019 | $410370 |
| Jun 30, 2019 | -$0.30 | -$0.23 | N/A | -29.59% | Miss | N/A | N/A | N/A | Aug 14, 2019 | $500 |
| Mar 31, 2019 | -$1.86 | -$1.56 | N/A | -19.23% | Miss | N/A | N/A | N/A | May 8, 2019 | $117755 |
| Dec 31, 2018 | -$1.56 | -$1.38 | N/A | -13.07% | Miss | N/A | N/A | N/A | Feb 5, 2019 | $53033 |
| Sep 30, 2018 | -$0.24 | -$0.24 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 30, 2018 | $54257 |
| Jun 30, 2018 | -$2.70 | -$0.10 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 8, 2018 | $73053 |
| Mar 31, 2018 | -$0.90 | -$0.09 | N/A | -900.00% | Miss | N/A | N/A | N/A | May 8, 2018 | $64052 |
| Dec 31, 2017 | -$0.93 | -$0.70 | N/A | -32.86% | Miss | N/A | N/A | N/A | Feb 5, 2018 | $20487 |
| Sep 30, 2017 | -$0.81 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 1, 2017 | $2880 |
| Jun 30, 2017 | -$0.84 | -$0.77 | N/A | -9.09% | Miss | N/A | N/A | N/A | Aug 9, 2017 | $20532 |
| Mar 31, 2017 | -$0.77 | -$0.70 | N/A | -10.00% | Miss | N/A | N/A | N/A | May 9, 2017 | $63019 |
| Dec 31, 2016 | -$1.05 | -$0.70 | N/A | -50.00% | Miss | N/A | N/A | N/A | Feb 6, 2017 | $141856 |
| Sep 30, 2016 | -$0.91 | -$0.91 | N/A | 0.00% | In line | N/A | N/A | N/A | Dec 14, 2016 | $276102 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Sep 30, 2026 was -$1.37, after -$1.35 the year before. It was -$3.47 for the year ended Sep 30, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Sep 30, 2026 | -$1.37 | N/A |
| Sep 30, 2025 | -$1.35 | N/A |
| Sep 30, 2024 | -$1.93 | N/A |
| Sep 30, 2023 | -$3.05 | N/A |
| Sep 30, 2022 | -$5.25 | N/A |
| Sep 30, 2021 | -$13.55 | N/A |
| Sep 30, 2020 | -$2.96 | N/A |
| Sep 30, 2019 | -$4.27 | N/A |
| Sep 30, 2018 | -$4.77 | N/A |
| Sep 30, 2017 | -$3.47 | N/A |
Frequently Asked Questions About EDSA
When is Edesa Biotech's next earnings date?
Edesa Biotech's next earnings report is expected for Dec 10, 2026.
Did EDSA beat earnings estimates last quarter?
No. Edesa Biotech reported EPS of -$0.60 for the quarter ended Jun 30, 2026, below the -$0.44 estimate by 36.36%.
What EPS do analysts expect from EDSA next quarter?
The consensus EPS estimate for Edesa Biotech for the quarter ended Sep 30, 2026 is -$0.59 from 5 analysts.
How often does EDSA beat earnings estimates?
Edesa Biotech beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -6.54%.
EDSA pages: Overview, Earnings, Financials, Competitors